REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr. Borkone es Tarsa Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Dr. Borkone es Tarsa Gyogyszerkiskereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Dr. Borkone es Tarsa Bt. is an enterprise in Hungary, with the main office in Szolnok. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was first established on November 17, 1995. Dr. Borkone es Tarsa Bt. currently employs 5 (2024) people. In 2023, the company reported a net sales revenue increase of 8.92%. During that time, Dr. Borkone es Tarsa Bt.’s total assets decreased by 3.78%. In 2023, Dr. Borkone es Tarsa Bt.’s net profit margin increased by 0.15%.

Headquarters
Csokonai u. 18. II /4.
Szolnok; Jasz-Nagykun-Szolnok; Postal Code: 5000

Contact Details: Purchase the Dr. Borkone es Tarsa Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Dr. Borkone es Tarsa Bt. report to view the information.
Outstanding Shares:
Purchase the Dr. Borkone es Tarsa Bt. report to view the information.
Registered Capital:
Purchase the Dr. Borkone es Tarsa Bt. report to view the information.
Incorporation Date:
November 17, 1995
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Dr. Borkone es Tarsa Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
8.92%▲
Total operating revenue
8.9%▲
Operating profit (EBIT)
-69.12%▼
EBITDA
130.93%▲
Net Profit (Loss) for the Period
444.83%▲
Total assets
-3.78%▼
Total equity
1.72%▲
Operating Profit Margin (ROS)
-1.34%▼
Net Profit Margin
0.15%▲
Return on Equity (ROE)
1.38%▲
Quick Ratio
-1.13%▼
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo